Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report

BACKGROUND: Transplant-eligible patients with polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome are treated with induction therapy and autologous stem cell transplantation. Conventional induction therapies may exacerbate neuropathy and a high rate of disease progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Taenaka, Ryutaro, Shimokawa, Sakurako, Katayama, Ayako, Nagao, Toshihiko, Obara, Teppei, Nishimura, Naoaki, Tsujimoto, Atsushi, Kohno, Kentaro, Aoki, Kenichi, Ogawa, Ryosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387014/
https://www.ncbi.nlm.nih.gov/pubmed/35978379
http://dx.doi.org/10.1186/s13256-022-03552-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387014/
https://www.ncbi.nlm.nih.gov/pubmed/35978379
http://dx.doi.org/10.1186/s13256-022-03552-y

Ejemplares similares